UBE3A p.Phe446=
c.1338T>C · rs371154816 · VCV196572
ClinGen expert panel — Rett and Angelman-like Disorders VCEP
Benign for Angelman syndrome. Applied ACMG criteria (verbatim):
BS1 BP7
Curation rationale (ClinGen, verbatim)
The allele frequency of the p.Phe426= variant in UBE3A (NM_130838.2) is 0.014% in European (non-Finnish) sub population in gnomAD, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Phe426= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP7). In summary, the p.Phe426= variant in UBE3A (NM_130838.2) is classified as Likely Benign based on the ACMG/AMP criteria (BS1, BP7).
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 2.6 | GERP -1.1, phastCons 1 |
| Overall | ||
| CADD | 7.96 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.0186% | 5,364 |
| Remaining individualsnot grpmax-eligible | 0.0096% | 10,418 |
| Admixed American | 0.00333% | 30,009 |
| African / African-American | 0.00133% | 75,062 |
| South Asian | 0.0011% | 91,080 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- UBE3A
- Protein
- p.Phe446=
- Coding
- c.1338T>C
- MANE Select
- NM_130839
- dbSNP
- rs371154816
- Type
- single nucleotide variant
- Location
- chr15:25370836 (GRCh38)
- Gene constraint
- LOEUF 0.139 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 81.42 · 25 PDB
- Residue 446
- the 'interaction with hcv core protein' region; an α-helix
Similar variants
- UBE3A c.2125-1G>A Likely pathogenic ★★★ same condition
- UBE3A p.Arg526Cys Pathogenic ★★★ same condition
- UBE3A p.Gly870Asp Likely pathogenic ★★★ same condition
- UBE3A c.1609-8A>G Uncertain significance ★★★ same condition
- UBE3A p.Asn581Ser Uncertain significance ★★★ ⚠ same condition
- UBE3A p.Cys137Arg Uncertain significance ★★★ ⚠ same condition
- UBE3A p.Phe805= Uncertain significance ★★★ same condition
- UBE3A p.Thr807Ala Uncertain significance ★★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ube3a-p-phe446 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown